Lyme Arthritis: Symptoms, Diagnosis, and Treatment

Lyme arthritis is the most common late-stage manifestation of Lyme disease in the United States, typically appearing months after an initial tick bite when the infection goes untreated or incompletely treated.¹ It produces intermittent or persistent swelling in one or a few large joints, with the knee affected far more than any other. Most people recover fully with a standard course of oral antibiotics, but a subset develops prolonged joint inflammation that persists even after the bacteria appear to be cleared, raising questions about autoimmunity and the limits of antibiotic therapy.

How Lyme Arthritis Develops

The bacterium Borrelia burgdorferi enters the skin through the bite of an infected blacklegged tick. If the infection isn’t caught and treated during the early rash stage, spirochetes can spread through the bloodstream and settle in joint tissue. A surface protein on the spirochete, called OspC, functions as an adhesive molecule that binds to connective-tissue components like fibronectin and dermatan sulfate. That binding is what allows the bacteria to cross from blood vessels into the joint lining.² Variation in the OspC sequence among different strains of the bacterium helps explain why some strains are more likely to cause joint disease than others.

Genetic differences in the infecting strain also influence how aggressively the bacteria disseminate and how severe the resulting disease becomes. Mouse studies comparing genetically distinct strains have shown that some produce far higher spirochete loads in the blood and tissues, and only the most aggressive strains caused severe arthritis and inflammation of the aorta.³ In practice, this means the strain you’re infected with matters for how likely you are to develop joint problems and how severe those problems might be.

What Lyme Arthritis Looks and Feels Like

The hallmark is a swollen, painful joint, almost always a large joint, and the knee is the most common target by a wide margin.⁴ People sometimes describe it as waking up with a knee that looks puffy and feels stiff, without any preceding injury. The swelling can be dramatic, with visible fluid accumulation. Ankles, elbows, wrists, hips, and shoulders are occasionally affected, but much less often than the knee.

One feature that surprises many patients is that the pain is often less intense than the swelling would suggest. A person with a knee ballooned up with fluid may still be able to walk on it, though range of motion is usually limited. Early on, episodes tend to come and go, with flares lasting days to weeks followed by periods of improvement. Without treatment, these recurring episodes can stretch on for months or years. Many people who develop Lyme arthritis never noticed the initial tick bite, and a significant number never had the characteristic bull’s-eye rash, which makes the diagnosis less obvious.

Diagnosing Lyme Arthritis

Diagnosis rests on the combination of a compatible clinical picture, a history of possible tick exposure, and blood tests for antibodies against B. burgdorferi. The standard approach uses a two-step blood test. The first step is a screening assay; if that is positive or borderline, a second, more specific test confirms the result.

This two-step method has a significant limitation in early Lyme disease: sensitivity at the earliest stage is poor, catching fewer than half of true cases, because the immune system hasn’t yet produced enough antibodies to detect.⁵ The good news for Lyme arthritis is that by the time joint disease appears, patients have had the infection for weeks or months, and their antibody response is robust. At this late stage, sensitivity is essentially complete, above 99% in one meta-analysis, with specificity consistently above 98%.⁵ In other words, if you truly have Lyme arthritis, your blood test will almost certainly come back positive. A negative result in a patient with a swollen knee in a Lyme-endemic area effectively rules it out.

One wrinkle worth noting, especially in children: results can vary depending on which specific screening test the lab uses for the first step. A study comparing different first-tier assays found that a substantial number of children got different results depending on the brand of test, which is why clinicians in areas where Lyme is common are advised to retest children when the clinical suspicion is high and the first result is negative.⁶

The Role of Joint Fluid Testing

When clinicians drain fluid from a swollen joint, they can send it for a test called PCR, which detects bacterial DNA. In untreated or partially treated patients, this test picks up spirochete DNA in the vast majority of cases. One landmark study found positive PCR results in 96% of patients who had not yet been adequately treated.⁷ Sensitivity drops sharply after proper antibiotic courses, which actually makes the test useful for a different reason: if PCR remains positive after treatment, the bacteria may not have been fully cleared. Among PCR methods used in Lyme diagnosis, joint fluid is uniquely reliable; the test performs poorly on samples from most other body sites.⁸

Separating Lyme Arthritis from a Septic Joint

A child or adult who shows up in an emergency department with a red, swollen knee in a Lyme-endemic region poses a common diagnostic dilemma: is this Lyme arthritis or a bacterial joint infection that needs emergency surgery? The distinction matters enormously because septic arthritis can destroy cartilage within hours, while Lyme arthritis, though unpleasant, is not a surgical emergency.

A large study of children presenting with a swollen knee found that about half had Lyme arthritis, only 3% had septic arthritis, and the rest had other inflammatory causes.⁹ Clinicians have developed prediction tools to help sort these out. One widely cited model identifies four risk factors that point toward septic arthritis rather than Lyme: pain with any joint motion, a history of fever, a CRP level above a certain threshold, and being younger than two years old. When none of these factors are present, the risk of a bacterial infection drops to about 2%, making it reasonable to hold off on surgery and wait for Lyme test results.¹⁰ As risk factors stack up, so does the probability of a true joint infection.

These scoring systems aren’t perfect, and a more recent study tested them in a geographically diverse population and found that additional factors like not bearing weight on the leg, elevated white blood cell count, and age under four also helped distinguish the two conditions. The researchers developed a five-factor algorithm that performed well, correctly classifying cases with an accuracy rate substantially higher than earlier models.¹¹ In practice, most emergency physicians in endemic areas will start by checking these simple clinical markers before deciding whether to take a child straight to the operating room.

First-Line Antibiotic Treatment

Standard treatment is a 28-day course of oral doxycycline or amoxicillin.¹² The original clinical trial that established these regimens found that the large majority of patients treated with either drug had their arthritis resolve within one to three months of starting treatment.¹³ If the arthritis doesn’t improve after the first round, a second 28-day oral course or a switch to an intravenous antibiotic like ceftriaxone is typically tried.

An important point that often confuses patients: even after the antibiotics are finished and the bacteria are eliminated, joint swelling may take weeks or even a couple of months to fully subside. This lag doesn’t necessarily mean the antibiotics failed. The immune response that was fighting the infection takes time to wind down, and residual inflammation can linger after the infection itself is gone. For this reason, clinicians usually wait at least a few months after completing antibiotics before deciding that a case is truly “refractory.”

When the Joint Stays Inflamed

Roughly a third of patients develop persistent joint inflammation lasting two months or more after completing appropriate antibiotics.¹⁴ In most of these people, the swelling eventually resolves on its own within a few additional months, but a small number go on to develop what is called antibiotic-refractory Lyme arthritis, where the immune system keeps attacking the joint lining long after the bacteria are gone.

The mechanism behind this is one of the more fascinating stories in rheumatology. The central problem appears to be a dysregulated immune response: during the active infection, the body ramps up inflammatory signals, particularly a molecule called IFNγ, while failing to produce enough of the anti-inflammatory counterbalance IL-10. This imbalanced state persists into the post-infection period.¹⁵ There is also evidence that molecular mimicry may be involved: a key immune target on the spirochete’s surface protein (OspA) resembles a human protein found on immune cells themselves, so the immune system may be cross-reacting with the body’s own tissue. Patients with treatment-resistant arthritis disproportionately carry certain genetic immune markers, and the severity and duration of their arthritis tracks with immune responses against OspA.¹⁶

Treatment Options for Refractory Cases

When antibiotics have been adequately tried and the joint remains inflamed, the approach shifts from targeting the bacterium to calming the immune system. Disease-modifying antirheumatic drugs, the same medications used for conditions like rheumatoid arthritis, are sometimes introduced. A national cohort study found that a small number of patients with persistent inflammation after documented bacterial clearance required these medications to reach remission.¹⁴ More recently, biologic drugs that target specific components of the inflammatory pathway have expanded the toolkit for these patients.¹⁷

Case reports illustrate what this looks like in practice. One particularly instructive case involved a patient whose chronic Lyme arthritis was unresponsive to repeated courses of doxycycline and ceftriaxone, as well as two conventional antirheumatic drugs. A TNF-blocking biologic helped partially, but the patient only achieved lasting remission after switching to tocilizumab, a drug that blocks the inflammatory signaling molecule IL-6.¹⁸ These drugs are used off-label for refractory Lyme arthritis and reserved for cases where standard treatment has clearly failed.

For the most stubborn cases, surgery can be an option. Arthroscopic synovectomy, in which the inflamed lining of the joint is removed through small incisions, has been used with good results. In one study following 20 patients for up to eight years after the procedure, 80% had their inflammation resolve and remain gone.¹⁹ The remaining 20% had persistent or recurrent inflammation. Complications, including joint stiffness from scarring, have been reported in some patients undergoing knee surgery for chronic Lyme arthritis, particularly when other structural problems like a meniscal tear are present.²⁰

Lyme Arthritis in Children

Children are among the most commonly affected populations, and Lyme arthritis in kids tends to look somewhat different from the adult version. Children are more likely to present acutely, with higher white blood cell counts both in the blood and in joint fluid, compared to adults.²¹ The bright side is that kids also tend to recover faster: children are significantly more likely to return to normal function within four weeks of starting antibiotics. Adults are more likely to need multiple antibiotic courses and to require intravenous treatment.

A long-term follow-up study of 46 children tracked over more than a decade found that attacks of arthritis, usually affecting the knee, became less frequent with each passing year. By the fourth year, only about a fifth of the original group was still having flares. Over ten years out, though, about a third of the children who could be reached for follow-up still reported occasional brief episodes of joint pain.²² That study predated modern antibiotic regimens, so outcomes with current treatment are likely better, but it underscores that Lyme arthritis isn’t always a quick fix.

A frequently missed diagnostic clue in children is the absence of a remembered tick bite or rash. In one study from Nova Scotia, only about a quarter of children with Lyme arthritis recalled a tick bite, and only three of 17 had a documented history of the bull’s-eye rash. The knee was involved in 94% of cases. The diagnosis was often not suspected by the referring physician, which delayed appropriate treatment.²³

How Joint Damage Happens

When inflammation from Lyme arthritis persists, it can eventually damage cartilage and other structures in the joint. A key part of this damage involves enzymes called matrix metalloproteinases, which are normally involved in tissue remodeling but become destructive when overproduced. The Lyme spirochete triggers human cartilage cells to ramp up production of several of these enzymes.²⁴ This matters for research, because mouse models of Lyme disease don’t reproduce this same pattern of enzyme activation, which means findings from mouse studies don’t always translate directly to human disease.

One specific enzyme, MMP-9, plays a particularly important role in driving inflammation. Mice that lack MMP-9 develop significantly less arthritis even when they carry the same number of spirochetes in their joints, suggesting the enzyme amplifies the inflammatory response rather than helping clear the infection. MMP-9 appears to do this by breaking down collagen in ways that attract more immune cells into the joint, creating a self-reinforcing cycle of inflammation.²⁵ Understanding these pathways is part of what makes researchers hopeful that targeted therapies can interrupt joint damage in patients whose immune systems won’t calm down on their own.

Long-Term Outcomes

The overall prognosis for Lyme arthritis is good, particularly when it’s caught and treated. A long-term follow-up of patients treated with intravenous ceftriaxone found that at three years, about three-quarters had a complete response or marked improvement. Roughly a quarter had relapses or new symptoms develop over that period.²⁶ For those who don’t respond and go on to need additional immune-suppressing treatment or surgery, permanent joint damage is possible but uncommon.

Financial burden is worth acknowledging as well. A study of medical costs in high-incidence areas found that disseminated Lyme disease, which includes Lyme arthritis, carried costs roughly double those of localized disease. Much of that cost comes from additional doctor visits, lab tests, and antibiotic courses, plus lost work time.²⁷ For people who develop the refractory form, the financial and personal toll climbs further with each added treatment step.

Prevention After a Tick Bite

The single most effective way to prevent Lyme arthritis is to prevent Lyme disease in the first place, and that starts at the moment a tick is found. A randomized trial showed that a single dose of doxycycline given within 72 hours of removing an attached blacklegged tick reduced the chance of developing the characteristic rash by about 87%.²⁸ A meta-analysis pooling data from multiple trials confirmed this protective effect, estimating that antibiotic prophylaxis after a tick bite prevents roughly one case of Lyme disease for every 50 people treated.²⁹

This prophylaxis is typically recommended in Lyme-endemic areas when the tick is identified as a blacklegged tick and was attached for at least 36 hours. Outside those parameters, the risk of infection from any single bite is low enough that watchful waiting is usually preferred. Still, prompt tick removal is critical regardless. The longer a tick feeds, the more likely it is to transmit the spirochete.

Emerging Research on Better Diagnostic Tools

Standard blood tests work well for Lyme arthritis, as noted earlier, but researchers are interested in biomarkers that could tell clinicians more than a simple yes-or-no infection result. One area of investigation involves changes in fat molecules circulating in the blood. Patients with Lyme arthritis show a distinct pattern of altered phospholipids compared to both healthy people and people with rheumatoid arthritis, with one particular lipid molecule showing especially strong potential as a distinguishing marker.³⁰ If validated in larger studies, markers like this could help separate Lyme arthritis from lookalike conditions more quickly.

Other researchers are studying markers of oxidative stress and inflammation in the blood and urine. Patients with Lyme arthritis show substantially elevated levels of certain lipid breakdown products, some increased several-fold compared to healthy people. One marker in particular, measured as a ratio between its free and bound forms, may prove useful as an indicator of active Lyme-related joint disease.³¹ Similarly, molecules from the prostaglandin pathway are elevated in Lyme arthritis and antibiotic-refractory cases, and levels drop after successful treatment, raising the possibility that they could serve as a way to monitor whether treatment is working.³² None of these biomarkers are ready for routine clinical use yet, but they represent a meaningful step toward more nuanced diagnostic and monitoring tools for a condition that still relies heavily on a single yes-or-no antibody test.